{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:40:26Z","timestamp":1754152826834,"version":"3.41.2"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272726"],"award-info":[{"award-number":["82272726"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Ovarian cancer (OV) continues to be the most lethal type of gynecological cancer with a poor prognosis. During tumorigenesis and cancer advancement, mitochondria are key players in energy metabolism. This study focuses on exploring the mitochondria-related genes for the prognosis of OV.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>RNA expression profiles and single-cell data were acquired from The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC), and Gene Expression Omnibus databases for screening and validating mitochondria-related differentially expressed genes (DEGs). After univariate Cox analysis, prognostic genes were carried out for modeling mitochondria signature (MS) based on 101 combinations of 10 machine learning algorithms. Functional enrichment analysis was performed on this prognostic gene set. Immune infiltration analysis was performed between MS groups. Validation for the prognostic model gene OAT was performed to identify the prognostic significance, combined with <jats:italic>in vitro<\/jats:italic> experiments to explore its expressions in OV cells. qRT-PCR assay was performed to examine the expression of OAT in human ovarian cancer cell samples and normal ovarian epithelial cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 21 prognostic mitochondria-related DEGs were identified for reliably constructing the model MS with excellent prognostic performance in OV. GO and KEGG analysis confirmed these genes were enriched in the generation of precursor metabolites and energy. It illustrated more lymphocyte infiltration in the high MS group than low MS group. OAT served as a novel biomarker for OV patients, showing poor survival in OV patients with high expression of OAT. qPCR assays confirmed its significantly high expression in human ovary cancer cell lines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The MS offers tailored risk evaluations and immunotherapy treatments for each OV patient. MS model gene OAT has been recognized as a new oncogene for OV linked to immune escape.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s12672-025-02892-7","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T12:34:10Z","timestamp":1753187650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Construction of mitochondrial signature (MS) for the prognosis of ovarian cancer"],"prefix":"10.1007","volume":"16","author":[{"given":"Miao","family":"Ao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixia","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomeng","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"2892_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","volume":"21","author":"PM Webb","year":"2024","unstructured":"Webb PM, Jordan SJ. Global epidemiology of epithelial ovarian cancer. Nat Rev Clin Oncol. 2024;21:389\u2013400. https:\/\/doi.org\/10.1038\/s41571-024-00881-3.","journal-title":"Nat Rev Clin Oncol"},{"key":"2892_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082184","author":"M Fabbro","year":"2020","unstructured":"Fabbro M, Colombo PE, Leaha CM, et al. Conditional probability of survival and prognostic factors in long-term survivors of high-grade serous ovarian cancer. Cancers. 2020. https:\/\/doi.org\/10.3390\/cancers12082184.","journal-title":"Cancers."},{"key":"2892_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12916-024-03826-w","volume":"23","author":"J Hillmann","year":"2025","unstructured":"Hillmann J, Maass N, Bauerschlag DO, Fl\u00f6rkemeier I. Promising new drugs and therapeutic approaches for treatment of ovarian cancer-targeting the hallmarks of cancer. BMC Med. 2025;23:10. https:\/\/doi.org\/10.1186\/s12916-024-03826-w.","journal-title":"BMC Med"},{"key":"2892_CR4","doi-asserted-by":"publisher","first-page":"972","DOI":"10.6004\/jnccn.2022.0047","volume":"20","author":"DK Armstrong","year":"2022","unstructured":"Armstrong DK, Alvarez RD, Backes FJ, et al. NCCN guidelines\u00ae insights: ovarian cancer, version 3.2022. J Natl Compr Canc Netw. 2022;20:972\u201380. https:\/\/doi.org\/10.6004\/jnccn.2022.0047.","journal-title":"J Natl Compr Canc Netw"},{"key":"2892_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/cac2.12416","volume":"43","author":"A Goenka","year":"2023","unstructured":"Goenka A, Khan F, Verma B, et al. Tumor microenvironment signaling and therapeutics in cancer progression. Cancer Commun. 2023;43:525\u201361. https:\/\/doi.org\/10.1002\/cac2.12416.","journal-title":"Cancer Commun"},{"key":"2892_CR6","doi-asserted-by":"publisher","unstructured":"Fang X, Wang Y, Wei H and Huang Y. Precision Microbiome: A New Era of Targeted Therapy with Core Probiotics. Research. 2025; https:\/\/doi.org\/10.34133\/research.0658.","DOI":"10.34133\/research.0658"},{"key":"2892_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-3-031-58311-7_7","volume":"1452","author":"H Schatten","year":"2024","unstructured":"Schatten H. The impact of mitochondria in ovarian cancer cell metabolism, proliferation, and metastasis. Adv Exp Med Biol. 2024;1452:119\u201325. https:\/\/doi.org\/10.1007\/978-3-031-58311-7_7.","journal-title":"Adv Exp Med Biol"},{"key":"2892_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20010229","author":"E Emmings","year":"2019","unstructured":"Emmings E, Mullany S, Chang Z, et al. Targeting mitochondria for treatment of chemoresistant ovarian cancer. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20010229.","journal-title":"Int J Mol Sci"},{"key":"2892_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179143","author":"A Zdanowicz","year":"2024","unstructured":"Zdanowicz A, Grosicka-Maci\u0105g E. The Interplay between autophagy and mitochondria in cancer. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25179143.","journal-title":"Int J Mol Sci."},{"key":"2892_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091350","author":"A Signorile","year":"2019","unstructured":"Signorile A, De Rasmo D, Cormio A, et al. Human ovarian cancer tissue exhibits increase of mitochondrial biogenesis and cristae remodeling. Cancers. 2019. https:\/\/doi.org\/10.3390\/cancers11091350.","journal-title":"Cancers"},{"key":"2892_CR11","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1186\/s12967-024-05770-y","volume":"22","author":"X Cui","year":"2024","unstructured":"Cui X, Xu J, Jia X. Targeting mitochondria: a novel approach for treating platinum-resistant ovarian cancer. J Transl Med. 2024;22:968. https:\/\/doi.org\/10.1186\/s12967-024-05770-y.","journal-title":"J Transl Med."},{"key":"2892_CR12","doi-asserted-by":"publisher","first-page":"5634724","DOI":"10.1155\/2022\/5634724","volume":"2022","author":"L Shen","year":"2022","unstructured":"Shen L, Zhan X. Mitochondrial dysfunction pathway alterations offer potential biomarkers and therapeutic targets for ovarian cancer. Oxid Med Cell Longev. 2022;2022:5634724. https:\/\/doi.org\/10.1155\/2022\/5634724.","journal-title":"Oxid Med Cell Longev"},{"key":"2892_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s12272-015-0550-6","volume":"38","author":"SW Kang","year":"2015","unstructured":"Kang SW, Lee S, Lee EK. ROS and energy metabolism in cancer cells: alliance for fast growth. Arch Pharm Res. 2015;38:338\u201345. https:\/\/doi.org\/10.1007\/s12272-015-0550-6.","journal-title":"Arch Pharm Res"},{"key":"2892_CR14","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1080\/09553002.2019.1589653","volume":"95","author":"P Vaupel","year":"2019","unstructured":"Vaupel P, Schmidberger H, Mayer A. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression. Int J Radiat Biol. 2019;95:912\u20139. https:\/\/doi.org\/10.1080\/09553002.2019.1589653.","journal-title":"Int J Radiat Biol"},{"key":"2892_CR15","doi-asserted-by":"publisher","first-page":"120902","DOI":"10.1016\/j.indcrop.2025.120902","volume":"228","author":"X Lai","year":"2025","unstructured":"Lai X, Zhao Y, Shi Z, et al. Plant-derived paclitaxel-loaded ultra-small Fe\u2083O\u2084 nanoparticles for MR imaging-mediated antitumor therapy. Ind Crops Prod. 2025;228:120902. https:\/\/doi.org\/10.1016\/j.indcrop.2025.120902.","journal-title":"Ind Crops Prod"},{"key":"2892_CR16","doi-asserted-by":"publisher","first-page":"102407","DOI":"10.1016\/j.redox.2022.102407","volume":"55","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang M, Liu Y, et al. Integrated regulation of stress responses, autophagy and survival by altered intracellular iron stores. Redox Biol. 2022;55:102407. https:\/\/doi.org\/10.1016\/j.redox.2022.102407.","journal-title":"Redox Biol"},{"key":"2892_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13046-022-02244-1","volume":"41","author":"X Li","year":"2022","unstructured":"Li X, Wang S, Mu W, et al. Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155\u20135p\/PD-L1 pathway. J Exp Clin Cancer Res. 2022;41:41. https:\/\/doi.org\/10.1186\/s13046-022-02244-1.","journal-title":"J Exp Clin Cancer Res"},{"key":"2892_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13045-022-01282-8","volume":"15","author":"Y Tie","year":"2022","unstructured":"Tie Y, Tang F, Wei YQ, Wei XW. Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets. J Hematol Oncol. 2022;15:61. https:\/\/doi.org\/10.1186\/s13045-022-01282-8.","journal-title":"J Hematol Oncol"},{"key":"2892_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021224","author":"D De Rasmo","year":"2023","unstructured":"De Rasmo D, Cormio A, Cormio G, Signorile A. Ovarian cancer: a landscape of mitochondria with emphasis on mitochondrial dynamics. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24021224.","journal-title":"Int J Mol Sci."},{"key":"2892_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","volume":"173","author":"MH Bailey","year":"2018","unstructured":"Bailey MH, Tokheim C, Porta-Pardo E, et al. Comprehensive characterization of cancer driver genes and mutations. Cell. 2018;173:371-85.e18. https:\/\/doi.org\/10.1016\/j.cell.2018.02.060.","journal-title":"Cell"},{"key":"2892_CR21","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3389\/fimmu.2019.01835","volume":"10","author":"L Monteran","year":"2019","unstructured":"Monteran L, Erez N. The dark side of fibroblasts: cancer-associated fibroblasts as mediators of immunosuppression in the tumor microenvironment. Front Immunol. 2019;10:1835. https:\/\/doi.org\/10.3389\/fimmu.2019.01835.","journal-title":"Front Immunol"},{"key":"2892_CR22","doi-asserted-by":"publisher","first-page":"e24692","DOI":"10.1002\/jcla.24692","volume":"36","author":"Z Jiang","year":"2022","unstructured":"Jiang Z, Wei C, Luo Y, et al. Ornithine aminotransferase and carbamoyl phosphate synthetase 1 involved in ammonia metabolism serve as novel targets for early stages of gastric cancer. J Clin Lab Anal. 2022;36:e24692. https:\/\/doi.org\/10.1002\/jcla.24692.","journal-title":"J Clin Lab Anal."},{"key":"2892_CR23","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1021\/acsmedchemlett.5b00153","volume":"6","author":"E Zigmond","year":"2015","unstructured":"Zigmond E, Ben Ya\u2019acov A, Lee H, et al. Suppression of hepatocellular carcinoma by inhibition of overexpressed ornithine aminotransferase. ACS Med Chem Lett. 2015;6:840\u20134. https:\/\/doi.org\/10.1021\/acsmedchemlett.5b00153.","journal-title":"ACS Med Chem Lett"},{"key":"2892_CR24","doi-asserted-by":"publisher","first-page":"12828","DOI":"10.1002\/jcp.27939","volume":"234","author":"Y Liu","year":"2019","unstructured":"Liu Y, Wu L, Li K, et al. Ornithine aminotransferase promoted the proliferation and metastasis of non-small cell lung cancer via upregulation of miR-21. J Cell Physiol. 2019;234:12828\u201338. https:\/\/doi.org\/10.1002\/jcp.27939.","journal-title":"J Cell Physiol"},{"key":"2892_CR25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.2174\/1872214811307020007","volume":"7","author":"A Gupta","year":"2013","unstructured":"Gupta A, Verma A, Mishra AK, et al. The Wnt pathway: emerging anticancer strategies. Recent Pat Endocr Metab Immune Drug Discov. 2013;7:138\u201347. https:\/\/doi.org\/10.2174\/1872214811307020007.","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"2892_CR26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s11912-010-0114-3","volume":"12","author":"OM Lucero","year":"2010","unstructured":"Lucero OM, Dawson DW, Moon RT, Chien AJ. A re-evaluation of the \u201concogenic\u201d nature of Wnt\/beta-catenin signaling in melanoma and other cancers. Curr Oncol Rep. 2010;12:314\u20138. https:\/\/doi.org\/10.1007\/s11912-010-0114-3.","journal-title":"Curr Oncol Rep"},{"key":"2892_CR27","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s12276-024-01170-w","volume":"56","author":"JU Lee","year":"2024","unstructured":"Lee JU, Song KS, Hong J, et al. Role of lung ornithine aminotransferase in idiopathic pulmonary fibrosis: regulation of mitochondrial ROS generation and TGF-\u03b21 activity. Exp Mol Med. 2024;56:478\u201390. https:\/\/doi.org\/10.1038\/s12276-024-01170-w.","journal-title":"Exp Mol Med"},{"key":"2892_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-014-0045-x","volume":"3","author":"SE Barnes","year":"2015","unstructured":"Barnes SE, Wang Y, Chen L, et al. T cell-NF-\u03baB activation is required for tumor control in vivo. J Immunother Cancer. 2015;3:1. https:\/\/doi.org\/10.1186\/s40425-014-0045-x.","journal-title":"J Immunother Cancer"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02892-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02892-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02892-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T12:34:11Z","timestamp":1753187651000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02892-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2892"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02892-7","relation":{},"ISSN":["2730-6011"],"issn-type":[{"type":"electronic","value":"2730-6011"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1388"}}